Skip to main content
Equibles

Point72 Asset Management, L.P.

Position in VIR — Vir Biotechnology, Inc.

CIK 1603466 STAMFORD, CT
Back to VIR Full portfolio

Position in VIR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$57,744,905
+$40,252,889 QoQ
Shares Held
5,666,821
+190.3% QoQ
Ownership
3.35%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#8
of 237 holders
Holding Since
Sep 2021
14 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Derivatives in VIR

reported options exposure · as of Jun 30, 2023
CallValue
$1,714,647
CallShares
69,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. VIR ranks #9 (2.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
 4,473,478 $158,316,386
2 CYTK
Cytokinetics Inc
 1,587,712 $135,257,185
3 BBIO
BridgeBio Pharma, Inc.
 1,525,782 $113,640,243
4 AXSM
Axsome Therapeutics, Inc.
 416,516 $101,950,621
5 LEGN
Legend Biotech Corp
 3,076,124 $88,838,461
6 MDGL
Madrigal Pharmaceuticals, Inc.
 137,029 $73,577,721
7 CELC
Celcuity Inc.
 650,916 $68,098,831
8 ACAD
Acadia Pharmaceuticals Inc
 2,433,168 $61,559,150

All Filings in VIR

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $57,744,905 5,666,821
2026-03-31 $17,492,016 1,952,234
2025-12-31 $1,180,179 195,718
2024-12-31 $6,227,652 848,454
2024-09-30 $39,060 5,215
2024-06-30 $156,640 17,600
2024-03-31 $329,225 32,500
2023-12-31 $80,480 8,000
2023-09-30 $29,047 3,100
2023-06-30 $1,714,647 69,900
2023-06-30 $12,549,548 511,600
2023-03-31 $39,165,737 1,683,100
2022-09-30 $1,050,682 54,496
2021-12-31 $86,047,037 2,055,100
2021-09-30 $944,384 21,700